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Abstract
Background: Global commitment to stop Human Immunodeficiency Virus (HIV) and ensure access to HIV
treatment calls for women empowerment, as these efforts play major roles in mother-to-child transmission. We
examined the association between women’s healthcare decision-making capacity and uptake of HIV testing in sub-
Saharan Africa.
Methods: We used data from the current Demographic and Health Surveys (DHS) of 28 countries in sub-Saharan
Africa, conducted between January 1, 2010 and December 31, 2018. At the descriptive level, we calculated the
prevalence of HIV testing in each of the countries. This was followed by the distribution of HIV testing across the
socio-demographic characteristics of women. Finally, we used binary logistic regression assess the likelihood of HIV
testing uptake by women’s health care decision-making capacity and socio-demographic characteristics. The results
were presented as Crude Odds Ratios (COR) and Adjusted Odds Ratios (AOR) with their corresponding 95%
confidence intervals signifying precision. Statistical significance was set at p-value < 0.05.
Results: We found that prevalence of HIV testing uptake in the 28 sub-Saharan African countries was 64.4%, with
Congo DR having the least (20.2%) and the highest occurred in Rwanda (97.4%). Women who took healthcare
decisions alone [COR = 3.183, CI = 2.880–3.519] or with their partners [COR = 2.577, CI = 2.335–2.844] were more
likely to test for HIV, compared to those whose healthcare decisions were taken by others, and this persisted after
controlling for significant covariates: [AOR = 1.507, CI = 1.321–1.720] and [AOR = 1.518, CI = 1.334–1.728] respectively.
Conclusion: Sub-Saharan African countries intending to improve HIV testing need to incorporate women’s
healthcare decision-making capacity strategies. These strategies can include education and counselling. This is
essential because our study indicates that the capacity of women to make healthcare decisions has an association
with decision to test for their HIV status.
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Background
Human Immunodeficiency Virus (HIV) and Acquired
Immune Deficiency Syndrome (AIDS) constitute one of
the world’s most serious public health problems [1].
Worldwide, an estimated 1.8 million newly infected HIV
cases were recorded in 2017 [1]. This was made up of
180,000 children predominantly living in sub-Saharan
Africa (SSA), who were infected by their HIV-positive
mothers during pregnancy, childbirth, or breastfeeding
[2]. HIV testing, especially among women aged 15–49, is
a challenge in SSA [3, 4]. Some of the challenges identified
in previous studies include but not limited to HIV-related
stigma from health professionals, HIV status disclosure di-
lemma, unintended pregnancy, intimate partner violence,
HIV and environmental structural barriers, distress, and
fear related to maternal and child health [3, 5]. The few
studies on this subject target women who access health
services in specific countries [6].
Global commitment to stopping new HIV infections
and ensuring access to treatment calls for women em-
powerment, due to the major role it plays in mother-to-
child-transmission [1, 7]. Women’s decision-making cap-
acity is imperative for ensuring HIV testing and address-
ing the pandemic [8], especially in SSA. The importance
of women’s decision-making capacity in the area of HIV
testing has been highlighted to build women’s confi-
dence to prevent HIV infection, especially mother to
child infection [9]. Women’s access to HIV testing de-
pends substantially on the level to which they have been
empowered to make decisions [10]. It is believed that a
woman who is empowered culturally, politically, or pro-
fessionally has the confidence to decide on HIV testing,
as she does not depend on her husband or partner to
make decision to test for HIV or not [11].
The Theory of Gender and Power (TGP) by Connell
[12] could guide the exploration of association between
women’s healthcare decision-making capacity and HIV
testing. The TGP postulates that power dynamics be-
tween men and women are manifested in three major
structures: sexual division of labour, sexual division of
power, structure of social exposure and affective at-
tachment [12, 13]. These structures provide a descrip-
tion of the gendered relationships between men and
women which explain the power and role dynamics
drifting more dominance to the males making the fe-
males subservient. Hence, a woman’s decision to go
for testing may depend on whether there is equality
between her and the partner, societal expectations,
and norms in relation to who should decide on going
for testing and whether or not there is male domin-
ance in the home. According to the theory, although
there is a distinction between these structures, they
overlap and thus may not be considered in isolation
from one other. These structures are also maintained
through societal and institutional social mechanisms
[13, 14]. These societal and institutional social mecha-
nisms include specific socio-demographic characteris-
tics of individuals.
For women, the specific socio-demographic character-
istics which, together with healthcare decision making
capacity, influence HIV testing include age, education,
wealth, employment, residence, and parity [8, 15]. In
SSA, literature on women’s decision-making capacity
and HIV testing is limited to specific countries such as
Tanzania [8], Ethiopia [16], and South Africa [17] and
mostly among women who are accessing healthcare ser-
vices at health facilities [18, 19]. This suggests the pau-
city of studies on women’s decision-making and HIV
testing in SSA. It is, therefore, imperative to conduct a
study in a broader context covering the entire SSA in
order to empower and imbue women with a positive at-
titude for HIV testing. In light of the foregoing, we ex-
amined women’s healthcare decision-making capacity
and HIV testing in SSA. We hypothesized that women
who have the capacity to take decisions on healthcare
alone or with their partners are more likely to test for
their HIV status. Findings from such a multi-country
study will provide evidence on the need and how to
strengthen existing strategies to improve HIV testing
and counselling by tackling women’s decision-making
capacity.
Methods
We used pooled data from the current Demographic
and Health Surveys (DHS) conducted from January 1,
2010 and December 31, 2018 in 28 countries in SSA (see
Fig. 1). DHS is a nationwide survey collected every five-
year period across low- and middle-income countries.
DHS focuses on maternal and child health by interview-
ing women of reproductive age (15–49 years) and men
between 15 and 64 years. DHS surveys followed the same
standard procedures – sampling, questionnaire develop-
ment, and data collection. However, data cleaning, coding,
and analysis were done in this study for cross-country
comparison. The survey employed a stratified two stage
sampling technique. The initial stage involved the selec-
tion of points or clusters (enumeration areas [EAs]),
followed by a systematic sampling of households listed in
each cluster or EA. For this study, the women’s file of the
DHS data was used. All the participants were women in
their reproductive age (15–49), who were usual members
of the selected households and/or visitors who slept in the
household on the night before the survey. In this study,
only women in unions who had complete information on
all the variables of interest were included (N = 195,307).
We relied on the “Strengthening the Reporting of Obser-
vational Studies in Epidemiology” (STROBE) statement in
writing the manuscript.
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Definition of variables
Outcome variable
The outcome variable was HIV testing uptake. It was de-
rived from the question “have you ever tested for HIV?”
and the responses were coded as “1=Yes and 0=No”.
Explanatory variables
Thirteen explanatory variables were considered in our
study, including the key explanatory variable (women’s
decision-making on healthcare). Women’s decision-making
on healthcare was derived from the question “Who usually
makes decisions about healthcare for yourself: you, your
(husband/partner), you and your (husband/partner) jointly,
or someone else?” The responses were categorised as re-
spondent alone, respondent and husband/partner, hus-
band/partner alone, someone else, and other. These were
recoded into respondent/woman alone = 1, respondent and
husband/partner = 2, husband/partner alone = 3 and
other = 4 (family members and friends).
Besides women’s decision-making on healthcare, 12 add-
itional variables were included in the study. These are sur-
vey country, age, educational level, marital status, religion,
wealth status, place of residence, parity, occupation, and ex-
posure to mass media (radio, television, and newspaper).
Apart from survey country which was predetermined based
on the geographical scope of the study, the selection of the
rest of the variables was based on their association with
HIV testing uptake in previous studies [6–8, 20–25].
Marriage was recoded into ‘married (1)’ and ‘cohabiting
(2)’. Occupation was captured as ‘not working (0)’, ‘man-
agerial (1)’, ‘clerical (2)’, ‘sales (3)’, ‘agricultural (4)’, ‘house-
hold/domestic (5)’, ‘services (6)’, and ‘manual (7)’. We
recoded parity (birth order) as ‘zero birth’(0), ‘one birth (1)’,
‘two births (2)’, ‘three births (3)’, and four or more births
(4)’. Lastly, religion was recoded as ‘Traditional religion (1)’,
‘Christianity (2)’, ‘Islam (3)’, ‘No religion (4)’, and ‘Other re-
ligion (5)’ (e.g. Hinduism, Buddhism, Atheism, Juddaism,
Taoism, Confucianism, Sikhism).
Fig. 1 Prevalence of HIV testing among women in SSA
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Statistical analyses
The data was analysed with STATA version 14.2 for Mac
OS. The analysis was done in three steps. The first step was
the computation of the prevalence of HIV testing uptake in
SSA (see Fig. 1). The second step was a cross-tabulation by
which we calculated the prevalence and proportions of HIV
testing across the socio-demographic characteristics (see
Table 1). Then, we conducted a bivariate logistic regression
(Model I) and multivariable regression (Model II) analyses
to assess the predictors of HIV testing among women in
SSA (see Table 2). All frequency distributions were
weighted and the survey command (svy) in STATA was
used to adjust for the complex sampling structure of the
data in the regression analyses. There was multicollinearity
between knowing a place for HIV testing and HIV testing
uptake. Due to this, it was taken out of the analysis. After it
was taken out, there was no evidence of multicollinearity
among the remaining variables (Mean VIF = 1.35, Max-
imum VIF = 1.70, Minimum VIF = 1.05). All results of the
logistic regression analyses were presented as Crude Odds
Ratios (CORs) and Adjusted Odds Ratios (AORs) at 95%
confidence intervals (CIs).
Results
Prevalence of HIV testing among women in sub-Saharan
Africa
Figure 1 shows the prevalence of HIV testing in entirety
and in each of the 28 SSA countries. Overall, the preva-
lence of HIV testing was 64.4%. We found that the
prevalence of HIV testing ranged from 20.2% in Congo
DR to 97.4% in Rwanda.
Socio-demographic characteristics and prevalence of HIV
testing
Table 1 summarises the prevalence of HIV testing across
the included socio-demographic characteristics. The
highest prevalence of HIV testing was among women
with higher education (92.9%) and the lowest prevalence
was among those who were Traditionalists (32.8%). All
the socio-demographic characteristics showed statisti-
cally significant relationship with HIV testing (Table 1).
Association between women’s healthcare decision-
making and socio-demographic characteristics on HIV
testing in sub-Saharan Africa
Table 2 shows results on the association between women’s
healthcare decision-making capacity and socio-
demographic factors associated with HIV testing among
women in SSA. The results indicate that women who took
healthcare decisions alone [COR = 3.183, CI = 2.880–
3.519] or with their partners [COR = 2.577, CI = 2.335–
2.844] were more likely to test for HIV compared to those
whose healthcare decisions were taken by others, and this
persisted after controlling for significant covariates
[AOR = 1.507, CI = 1.321–1.720] and [AOR = 1.518, CI =
1.334–1.728], respectively (see Model II). With the covari-
ates, women aged 20–24 [AOR = 1.351- CI = 1.273–
1.433], richest women [AOR= 2.561, CI = 2.418–2.713],
those with parity 4 or more [AOR = 4.788- CI = 4.488–
5.108] were more likely to test for HIV, compared to those
aged 15–19, those in the poorest wealth quintile, and
those with parity 0, respectively. On the other hand,
women aged 45–49 [AOR = 0.383, CI = 0.355–0.413],
those with no formal education [AOR = 0.259, CI = 0.227–
0.294], married women [AOR= 0.914, CI = 0.879–0.951],
those with no religion [AOR = 0.771, CI = 0.682–0.873],
those who were not working [AOR = 0.589, CI = 0.471–
0.737], those in agriculture [AOR = 0.571, CI = 0.456–
0.716], those in rural areas [AOR = 0.732, CI = 0.707–
0.759], those not exposed to newspaper [AOR = 0.656CI =
0.510–0.843], those not exposed to radio [AOR = 0.757,
CI = 0.693–0.828], those not exposed to television [AOR =
0.631, CI = 0.575–0.691], and those in Congo DR [AOR=
0.010,CI = 0.007–0.013] were less likely to test for HIV,
compared with those aged 15–19, those with higher edu-
cation, those cohabiting, those belonging to other religious
groups, those in clerical jobs, those in urban areas, those
who read newspaper almost every day, those who listened
to radio almost every day, those who watched television
almost every day, and those in Lesotho.
Discussion
This study examined the association between women’s
healthcare decision-making capacity and HIV testing up-
take in SSA, using the most recent DHS of 28 countries.
This study was imperative since HIV testing has been
noted as a challenge for some women in SSA [3] whilst
some evidence suggests that decision-making capacity
plays a significant role in whether a woman will test for
HIV or not [11, 26]. We found that women who had high
capacity to make decisions relating to their health either
alone or with their partners were more likely to test for
HIV. This may not necessarily imply that women who did
not have the capacity do not prioritise HIV testing; in-
stead, it may indicate their inability to translate their
thoughts into action. This finding reinforces evidence
from Tanzania and Nigeria that empowered women who
are capable of making decisions have higher chances of
HIV testing [8, 25]. In line with TGP, the finding indicates
that HIV testing among women can occur in empowered
women through a reduction in gender inequality, positive
societal expectation of women’s decision-making capacity
in marriage, and absence of male dominance. Our finding
suggests that efforts to halt HIV and vertical transmission
need to target decision-making capacity of women in the
household and community level. Additionally, facility-
based interventions such as supplying and subsidising the
cost of antiretroviral vaccines will be necessary. Active
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Table 1 Socio-demographic characteristics and prevalence of HIV testing among women in SSA
Variables Weighted Weighted HIV testing
N % No(%) Yes(%)
Age (p < 0.001)
15–19 11,471 5.9 45.8 54.2
20–24 33,274 17 31.5 68.5
25–29 42,429 21.7 30.5 69.5
30–34 38,061 19.5 30.5 69.5
35–39 31,407 16.1 34.8 65.2
40–44 22,159 11.4 39.6 60.4
45–49 16,506 8.5 49.4 50.6
Education (p < 0.001)
No formal education 75,990 38.9 54.8 45.2
Primary 66,398 34 24.3 75.7
Secondary 45,690 23.4 21.6 78.4
Higher 7229 3.7 7.1 92.9
Marital status (p < 0.001)
Married 158,959 81.4 36.1 63.9
Cohabitation 36,348 18.6 29.5 70.6
Religion (p < 0.001)
Traditionalist 4110 2.1 67.3 32.8
Christianity 118,237 60.5 24.1 76.0
Islam 65,606 33.6 51.0 49.0
No religion 4063 2.1 50.9 49.1
Other religion 3291 1.7 43.3 56.7
Wealth status (p < 0.001)
Poorest 36,699 18.8 46.3 53.7
Poorer 39,136 20 42.0 58.0
Middle 39,007 20 38.5 61.5
Richer 40,035 20.5 30.2 69.8
Richest 40,430 20.7 18.9 81.1
Occupation (p < 0.001)
Not working 52,787 27 36.2 63.8
Managerial 8145 4.2 11.9 88.1
Clerical 1397 0.7 10.1 89.9
Sales 34,960 17.9 38.0 62.0
Agriculture 68,862 35.3 39.4 60.6
Household/domestic 3581 1.8 16.2 83.8
Services 9491 4.9 28.8 71.2
Manual 16,084 8.2 26.1 73.9
Place of Residence (p < 0.001)
Urban 65,252 33.4 25.1 74.9
Rural 130,055 66.6 39.8 60.2
Parity (p < 0.001)
0 11,690 6.0 47.5 52.5
1 30,413 15.6 28.5 71.5
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community engagement geared towards women em-
powerment especially in the areas of decision-making,
therefore, needs to be prioritised. A recent systematic re-
view indicated that encouragement from peers could en-
hance ability of women to undergo HIV test [27] and this
is a key community-level strategy. Testing for HIV was
high among women from Rwanda. This is not surprising
in light of the upsurge in health sector reforms in Rwanda
in the past few years [28]. Another factor that might have
accounted for the high likelihood of HIV testing in
Rwanda may be Rwanda’s continual efforts marked by
3.0% stabilised HIV prevalence among the general popula-
tion and 50% reduction in new HIV infection rate [29].
Rwanda is more likely to further improve in HIV testing
and reduction with the introduction of self-HIV-testing
kit which can be purchased over the counter [29]. There is
the need to encourage women in DR Congo to utilise
HTC.
In relation to the covariates, the study revealed that
HIV testing declines as women advance in age and par-
ity but increases among women with higher educational
attainment, those with richest wealth quintile, urban
women, women who have knowledge on HIV, and those
who are exposed to media. The findings on age and par-
ity are consistent with earlier studies conducted in a
number of SSA countries. For instance, one study from
Namibia reported that the likelihood of HIV testing gen-
erally declined as women advanced in age [22]. It is pos-
sible that women who are advanced in age and possibly
with high parity will feel that they have limited exposure
to HIV due to possible decline in sexual intercourse
[30]. Such women may feel less motivated to test for
HIV. In terms of socio-economic status, education,
urban living, and wealth status have been identified as
strong predictors for HIV testing in previous studies [21,
23, 25, 31–37]. Education and wealth status are forms of
empowerment. Hence, it is not surprising that such
women exercise their decision-making capacity in a way
that can improve their health status, which is testing for
HIV. This indicates that policies on mother-to-child-
transmission (MTCT) and plans to halt HIV need to
consider measures that can enhance economic standing
Table 1 Socio-demographic characteristics and prevalence of HIV testing among women in SSA (Continued)
Variables Weighted Weighted HIV testing
N % No(%) Yes(%)
2 33,833 17.3 27.5 72.5
3 30,030 15.4 30.4 69.6
4+ 89,340 45.7 39.8 60.3
Frequency of Reading newspaper (p < 0.001)
Not at all 163,600 83.8 39.0 61.1
Less than once a week 17,748 9.1 14.1 86.0
At least once a week 12,978 6.7 14.0 86.0
Almost every day 981 0.5 13.4 86.7
Frequency of Listening radio (p < 0.001)
Not at all 77,374 39.6 42.3 57.7
Less than once a week 39,034 20 34.5 65.6
At least once a week 73,723 37.8 28.1 71.9
Almost every day 5176 2.7 24.2 75.8
Frequency of Watching television (p < 0.001)
Not at all 117,427 60.1 39.3 60.7
Less than once a week 23,423 12 34.7 65.3
At least once a week 45,498 23.3 27.0 73.0
Almost every day 8960 4.6 18.2 81.8
Decision maker on health (p < 0.001)
Respondent alone 35,943 18.4 23.5 76.5
Respondent and husband/partner 78,870 40.4 27.9 72.1
Husband alone 78,951 40.4 46.8 53.2
Other 1543 0.8 50.1 49.9
*P values are from chi-square test
*Other religion (e.g. Hinduism, Buddhism, Atheism, Juddaism, Taoism, Confucianism, Sikhism)
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Table 2 Logistic regression analysis on women’s healthcare decision-making capacity and HIV testing in SSA
Variables Model I COR (95%CI) Model II AOR (95%CI)
Decision maker on health
Respondent alone 3.183***[2.880–3.519] 1.507***[1.321–1.720]
Respondent and husband/partner 2.577***[2.335–2.844] 1.518***[1.334–1.728]






30–34 1.901***[1.822–1.983] 1.229*** [1.150–1.312]
35–39 1.583***[1.516–1.652] 0.964 [0.900–1.032]
40–44 1.242***[1.187–1.299] 0.658*** [0.613–0.708]
45–49 0.866***[0.826–0.908] 0.383***[0.355–0.413]
Education









Christianity 3.073***[2.871–3.290] 1.070 [0.969–1.181]
Islam 0.920* [0.859–0.985] 0.787***[0.710–0.873]
No religion 0.971 [0.887–1.062] 0.771***[0.682–0.873]








Not working 0.190*** [0.158–0.227] 0.589***[0.471–0.737]
Managerial 0.796* [0.658–0.963] 0.879 [0.693–1.117]
Clerical Ref Ref
Sales 0.178*** [0.149–0.213] 0.739**[0.591–0.926]
Agriculture 0.160*** [0.133–0.191] 0.571*** [0.456–0.716]
Household/domestic 0.588*** [0.480–0.719] 0.634***[0.491–0.820]
Services 0.254*** [0.211–0.305] 0.734**[0.583–0.924]
Manual 0.308*** [0.257–0.370] 0.678***[0.540–0.852]
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Table 2 Logistic regression analysis on women’s healthcare decision-making capacity and HIV testing in SSA (Continued)
Variables Model I COR (95%CI) Model II AOR (95%CI)
Residence
Urban Ref Ref
Rural 0.505*** [0.494–0.515] 0.732***[0.707–0.759]
Parity
0 Ref Ref
1 2.267*** [2.169–2.370] 4.193***[3.941–4.461]
2 2.351*** [2.250–2.456] 4.382***[4.114–4.668]
3 2.056*** [1.968–2.149] 4.401***[4.120–4.702]
4+ 1.345*** [1.294–1.399] 4.788*** [4.488–5.108]
Newspaper
Not at all 0.241*** [0.196–0.297] 0.656***[0.510–0.843]
Less than once a week 0.974 [0.788–1.205] 0.844 [0.654–1.088]
At least once a week 0.904 [0.730–1.119] 0.767*[0.594–0.991]
Almost every day Ref Ref
Radio
Not at all 0.468*** [0.439–0.499] 0.757***[0.693–0.828]
Less than once a week 0.661*** [0.619–0.706] 0.958 [0.874–1.051]
At least once a week 0.897*** [0.840–0.956] 0.982 [0.896–1.075]
Almost every day Ref Ref
Television
Not at all 0.328*** [0.309–0.349] 0.631***[0.575–0.691]
Less than once a week 0.421*** [0.395–0.450] 0.766***[0.696–0.842]
At least once a week 0.606*** [0.569–0.646] 0.824*** [0.752–0.903]
Almost every day Ref Ref
Survey country
Burkina Faso 0.019***[0.015–0.025] 0.0382***[0.0284–0.0515]
Benin 0.029***[0.022–0.038] 0.0430***[0.0319–0.0579]
Burundi 0.413***[0.310–0.551] 0.890 [0.657–1.205]
DR Congo 0.010***[0.007–0.012] 0.010***[0.007–0.013]
Congo 0.020***[0.015–0.027] 0.0208***[0.0154–0.0282]
Cote D’Ivoire 0.027***[0.020–0.036] 0.0470***[0.0348–0.0635]
Cameroon 0.159***[0.119–0.210] 0.269***[0.200–0.363]









Malawi 0.788 [0.591–1.050] 1.432*[1.058–1.938]
Mozambique 0.112***[0.084–0.149] 0.269***[0.198–0.365]
Namibia 0.421***[0.310–0.570] 0.446***[0.322–0.616]
Seidu et al. BMC Public Health         (2020) 20:1592 Page 8 of 11
of women. This is in line with the Health Belief Model,
which argues that gaining consciousness about a health
condition is the first step to inform the needed precau-
tion [37, 38]. Women of high socio-economic status
(education and wealth) are also more likely to have
knowledge of HIV. This finding is consistent with previ-
ous evidence from Burkina Faso and Cambodia that
knowledge about HIV have greater implication on
whether women will undergo the test or otherwise [23,
39, 40]. Such knowledge can be obtained from exposure
to media, which can enhance HIV testing as indicated in
previous studies [38–40, 41, 42].
Strengths and limitations
This study offers a true account of women’s decision-
making capacity on healthcare and HIV testing emerging
from most recent national surveys of 28 countries in
SSA. The large sample and rigour of the methodological
and analytical approaches are significant strengths of the
study. However, the study is not devoid of limitations.
The predictors exposed in this study only account for
less than half of the variability in HIV testing in SSA and
that other factors on the demand and supply side are
likely to explain the bigger proportion of the variability
in HIV testing across the region. Again, women were
only asked if they had tested for HIV without any valid-
ation and as a result recall bias could occur. However,
these do not outweigh the rigour of the study in light of
the acknowledged strengths. Previous studies have estab-
lished strong associations between knowing a place to
get tested, comprehensive knowledge of HIV/AIDS, and
discriminatory attitude towards people living with HIV
and HIV testing, however, these variables were not con-
sistent across the countries we included in our analysis.
Therefore, we did not add them to our study. Knowing a
place to get tested showed high level of multicollinearity
and was dropped.
Conclusions and policy implications
The study has demonstrated that ensuring women’s
healthcare decision-making capacity has the propensity
to increase HIV testing uptake among women in SSA.
SSA countries that seek to improve HIV testing need to
incorporate women’s healthcare decision-making strat-
egies into the available policies because our study indi-
cates that as more women are able to make decisions in
their household relating to their health, their chances of
HIV testing increases. In addition to focusing on
provision of care (i.e., providing HIV test kits, targeting
household and community level structures), prioritising
women’s decision-making capacities can contribute posi-
tively to HIV testing. Much of this effort is required in
DR Congo as women from that country had the least
likelihood of HIV testing. Other category of women to
target when developing measures to increase HIV testing
are the poorest and married women, women over 45
years, those not having formal education, agricultural
workers, rural women, nulliparous women, women hav-
ing more than four births, and women having limited
contact with mass media (television, radio, and news-
paper). Various context-specific mass media channels
can, therefore, be used to reach the identified category
of women depending on available resources.
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